Rash, neutrophil-lymphocyte ratio (NLR) and survival in the REAL3 trial von Smyth, E.C., Kouvelakis, K., Peckitt, C., Waddell, T., Watkins, D., Rao, S., Starling, N., Saffery, C., Okines, A.F., Chau, I., Cunningham, D.

Volltext

Prognostic gene expression signature in chemotherapy treated patients from the MAGIC trial von Smyth, E.C., Nyamundanda, G., Cunningham, D., Tan, I.B., Fontana, E., Ragulan, C., Okines, A.F., Lin, S., Wotherspoon, A., Nankivell, M., Peckitt, C., Valeri, N., Langley, R.E., Tan, P., Sadanandam, A.

Volltext

Genomic loss of heterozygosity and survival in the REAL3 trial von Smyth, E.C, Cafferkey, C, Loehr, A, Waddell, T, Begum, R, Peckitt, C, Harding, T.C, Nguyen, M, Okines, A.F, Raponi, M, Rao, S, Watkins, D, Starling, N, Middleton, G.W, Wadsley, J, Mansoor, W, Crosby, T, Wotherspoon, A, Chau, I, Cunningham, D

Volltext bestellen

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o... von Cunningham, D, Stenning, S.P, Smyth, E.C, Okines, A.F, Allum, W.H, Rowley, S, Stevenson, L, Grabsch, H.I, Alderson, D, Crosby, T, Griffin, S.M, Mansoor, W, Coxon, F.Y, Falk, S.J, Darby, S, Sumpter, K.A, Blazeby, J.M, Langley, R.E

Volltext bestellen